Skip to main navigation Skip to search Skip to main content

Apremilast for immune checkpoint inhibitor-associated psoriasis and psoriatic arthritis: A systematic review

Research output: Contribution to journalReview articlepeer-review

Original languageEnglish
Pages (from-to)149-152
Number of pages4
JournalJAAD Reviews
Volume2
DOIs
StatePublished - Dec 2024

Keywords

  • apremilast
  • cutaneous adverse events
  • immune checkpoint inhibitors
  • immune-induced psoriasis
  • immune-related adverse events
  • phosphodiesterase inhibitor
  • psoriasis

Cite this